HK1029932A1 - Use of mirtazapine for the manufacture of a medicament for treating sleep apneas. - Google Patents

Use of mirtazapine for the manufacture of a medicament for treating sleep apneas.

Info

Publication number
HK1029932A1
HK1029932A1 HK01100800A HK01100800A HK1029932A1 HK 1029932 A1 HK1029932 A1 HK 1029932A1 HK 01100800 A HK01100800 A HK 01100800A HK 01100800 A HK01100800 A HK 01100800A HK 1029932 A1 HK1029932 A1 HK 1029932A1
Authority
HK
Hong Kong
Prior art keywords
mirtazapine
medicament
manufacture
treating sleep
sleep apneas
Prior art date
Application number
HK01100800A
Other languages
English (en)
Inventor
John Stuart Andrews
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of HK1029932A1 publication Critical patent/HK1029932A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK01100800A 1997-11-14 2001-02-05 Use of mirtazapine for the manufacture of a medicament for treating sleep apneas. HK1029932A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97203548 1997-11-14
PCT/EP1998/007330 WO1999025356A1 (en) 1997-11-14 1998-11-13 Use of mirtazapine for treating sleep apneas

Publications (1)

Publication Number Publication Date
HK1029932A1 true HK1029932A1 (en) 2001-04-20

Family

ID=8228923

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01100800A HK1029932A1 (en) 1997-11-14 2001-02-05 Use of mirtazapine for the manufacture of a medicament for treating sleep apneas.

Country Status (21)

Country Link
US (1) US6303595B1 (no)
EP (1) EP1030667B1 (no)
JP (1) JP2001522891A (no)
KR (1) KR20010032009A (no)
CN (1) CN1154495C (no)
AT (1) ATE289816T1 (no)
AU (1) AU737590B2 (no)
BR (1) BR9815098A (no)
CA (1) CA2309744A1 (no)
CZ (1) CZ296282B6 (no)
DE (1) DE69829202T2 (no)
DK (1) DK1030667T3 (no)
ES (1) ES2238781T3 (no)
HK (1) HK1029932A1 (no)
HU (1) HUP0100080A3 (no)
IL (2) IL135825A0 (no)
NO (1) NO20002218L (no)
PL (1) PL192272B1 (no)
PT (1) PT1030667E (no)
TR (1) TR200001293T2 (no)
WO (1) WO1999025356A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060241164A1 (en) * 1998-02-27 2006-10-26 The Board Of Trustees Of The University Of Illinoi Pharmacological treatment for sleep apnea
US7160898B2 (en) 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
JP2002504510A (ja) 1998-02-27 2002-02-12 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイ 睡眠時無呼吸に対する処置のための、セロトニン関連活性を有する薬剤
DK1257278T3 (da) * 2000-02-11 2006-06-12 Akzo Nobel Nv Anvendelse af mirtazapin til behandling af sövnforstyrrelser
US20020183306A1 (en) * 2001-05-30 2002-12-05 Pfizer Inc. Combination treatment for sleep disorders including sleep apnea
UA83666C2 (ru) 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
US7838029B1 (en) * 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
ES2426915T3 (es) 2003-09-10 2013-10-25 Brentwood Equities Ltd. Diastereoisómeros de 4-ariloxi-3-hidroxipiperidinas
WO2006023703A2 (en) * 2004-08-20 2006-03-02 Cypress Bioscience, Inc. Method for treating sleep related breathing disorders
US20060122127A1 (en) * 2004-11-17 2006-06-08 Cypress Bioscience, Inc. Methods for reducing the side effects associated with mirtzapine treatment
US8512751B2 (en) 2004-12-20 2013-08-20 Collegium Pharmaceutical, Inc. Pharmaceutical compositions for sleep disorders
MX2009010967A (es) 2007-04-11 2009-12-15 Organon Nv Un metodo para la preparacion de mirtazapina.
EP2167096A4 (en) * 2007-06-13 2010-07-14 Cypress Bioscience Inc IMPROVING TOLERANCE TO MIRTAZAPINE AND A SECOND ACTIVE INGREDIENT BY THE COMBINED USE OF THEM
WO2013188806A1 (en) * 2012-06-14 2013-12-19 The Regents Of The University Of Michigan Sleep apnea treatment
JP6876003B2 (ja) 2015-02-27 2021-05-26 デクラ リミテッド イヌ及びネコにおける、食欲の刺激、体重減少の管理、及び拒食症の処置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
EP0517984A1 (en) 1991-06-11 1992-12-16 Merrell Dow Pharmaceuticals Inc. Derivatives of amide analogs of certain methano bridged quinolizines
CA2235854A1 (en) * 1995-10-24 1997-05-01 The Trustees Of The University Of Pennsylvania Method of inhibiting sleep apnea
SE9504537D0 (sv) 1995-12-19 1995-12-19 Jan Hedner Sätt att behandla och diagnosticera andningsstörningar under sömn och medel för utförande av sättet
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
US6117855A (en) * 1996-10-07 2000-09-12 Merck Sharp & Dohme Ltd. Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent

Also Published As

Publication number Publication date
HUP0100080A2 (hu) 2001-08-28
CZ296282B6 (cs) 2006-02-15
DE69829202D1 (de) 2005-04-07
EP1030667B1 (en) 2005-03-02
ATE289816T1 (de) 2005-03-15
IL135825A (en) 2006-12-31
CN1154495C (zh) 2004-06-23
EP1030667A1 (en) 2000-08-30
PT1030667E (pt) 2005-06-30
AU737590B2 (en) 2001-08-23
AU1754899A (en) 1999-06-07
CZ20001751A3 (cs) 2000-10-11
ES2238781T3 (es) 2005-09-01
WO1999025356A1 (en) 1999-05-27
KR20010032009A (ko) 2001-04-16
CN1278731A (zh) 2001-01-03
IL135825A0 (en) 2001-05-20
BR9815098A (pt) 2000-10-10
CA2309744A1 (en) 1999-05-27
DK1030667T3 (da) 2005-06-20
NO20002218L (no) 2000-05-12
US6303595B1 (en) 2001-10-16
PL340467A1 (en) 2001-02-12
PL192272B1 (pl) 2006-09-29
NO20002218D0 (no) 2000-04-28
DE69829202T2 (de) 2005-07-21
HUP0100080A3 (en) 2002-05-28
JP2001522891A (ja) 2001-11-20
TR200001293T2 (tr) 2002-09-23

Similar Documents

Publication Publication Date Title
HK1029932A1 (en) Use of mirtazapine for the manufacture of a medicament for treating sleep apneas.
MX9700886A (es) Nuevas oxazolidinonas sustituidas.
RS20090083A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta -mimetics
BR0108977A (pt) Compostos azacìclicos para uso no tratamento de doenças relaciondas com serotonina
HK1060067A1 (en) Compositions for antitumour treatment containing ecteinascidin 743
SE9802208D0 (sv) Novel compounds
DK0973544T3 (da) Immuntolerant prothrombinkomplekspræparat
HK1048308A1 (en) Novel compounds.
GB0018951D0 (en) Novel compounds
EP1274414A4 (en) NASAL ADMINISTRATION OF AGENTS FOR THE TREATMENT OF GASTROPARESE
NZ528164A (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
DE69227583D1 (de) Arylmorpholine, herstellung und verwendung
SE0004101D0 (sv) New use
SE9802209D0 (sv) Novel compounds
GB0027705D0 (en) Novel compounds
MXPA02012911A (es) Compuestos de rutenio (ii) para el uso en terapia del cancer.
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
IL131478A0 (en) Methods for treatment of scar tissue
EP1056458A4 (en) METHODS FOR TREATING PAIN, INCLUDING CHRONIC AND WOMAN-SPECIFIC PAIN
SE9800139D0 (sv) New use
MY118982A (en) Method of reducing tissue damage associated with ischemia
AU2002211217A1 (en) Method of treating stroke
SE9802207D0 (sv) Novel compounds
MX9909548A (es) Metodos para la reduccion de fibrinogenos.
ES2148057A1 (es) Nuevo uso del diacepam como potenciador del efecto de los inhibidores pde 3

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20091113